enGene Therapeutics Inc.

Biological Products, (No Diagnostic Substances) | SIC: 2836
Phone: (514) 332-4888
CIK: 0001980845
State of Inc.: Z4
Tickers:
  • Nasdaq:ENGN
  • Nasdaq:ENGNW

Form: EFFECT

Filing Date: 02 Mar 2026
Report Date:
Accepted: 02 Mar 2026 10:15 p.m.
Accession Number: 9999999995-26-000700
Act: 33
File Number: 333-293597
Film Number: 26710922
Items: ,,

Documents

Primary Document
Accepted: 02 Mar 2026 10:15 p.m.